Southfield, MI – CFI USA (P&M Corporate Finance, LLC) is pleased to announce that it served as the exclusive financial advisor to Eagle Pharmacy (“Eagle”) in its sale to J. Knipper and Company (“Knipper”), a portfolio company of Court Square Capital Partners.
Headquartered in Lakeland, Florida, Eagle is a direct-to-patient pharmacy that serves patients who choose to take brand name medications. Eagle provides pharmaceutical manufacturers control over their distribution channel while meeting the manufacturers’ stringent storage and handling requirements to ensure patient safety. Eagle’s leadership team collectively has more than 50 years of experience in the pharmacy industry.
Knipper is one of the largest suppliers of end-to-end pharmaceutical samples management services in the United States and has more than 30 years of healthcare service experience. Headquartered in Lakewood, New Jersey, Knipper has additional locations in New Jersey, Indiana, and California.
“Eagle’s drug manufacturer programs are supported by its home delivery pharmacy that has consistently demonstrated unparalleled patient safety and delivery of high-level service to patients, physicians, and manufacturers. We are delighted to join J. Knipper and Company and are excited by the opportunity to leverage our combined expertise so that patients and prescribers can have a streamlined alternative to traditional pharmacy channels with transparent timelines and a host of online patient services,” said Stacy Huss, President, Eagle Pharmacy.
CFI USA’s Medical Technology Team served as the exclusive investment banker to Eagle Pharmacy, managing the entire transaction process. Huss commented, “PMCF not only led our Company through a successful transaction, but also helped guide us through the deal preparation process. Their expertise was crucial in advising us on the optimal time to launch to maximize value. There were unique and unforeseen challenges in completing a transaction during the pandemic, but PMCF’s creative thinking and leadership ensured a successful outcome for our team.”
The transaction closed in November 2020.
The testimonials may not be representative of the experience of other clients and are no guarantee of future performance or success.
Introduction of the strategic investor
to the pharmacy chain